Ascaris sp. and Vaccinia virus (VACV) co-infection aggravates the virus-associated pathology. Ascaris sp. and VACV co-infection enhances virus titres in the lung, leading to a marked increase in mortality. A reduction in CD4+IFN-γ+ T cells is associated with increased morbidity in co-infection. There is a negative association between the coincident larval Ascaris and respiratory VACV infection. Co-infected mice presented a marked decrease in the total number of migrating Ascaris lung-stage larvae.